Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mortality risk model for acute myocardial infarction complicated by cardiogenic shock: development, external validation, and exploratory application in a VA-ECMO cohort.

Created on 27 Oct 2026

Authors

Jinfeng Lin, Shushu Lu, Yadong Wang, Chunfeng Gu, Xudong Han, Junxian Xu

Published in

BMC medical informatics and decision making. Volume 26. Issue 1. Jul 29, 2026. Epub Jul 29, 2026.

Abstract

Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) carries a high risk of in-hospital death. Randomized evidence does not support routine VA-ECMO use in unselected AMI-CS populations. Objective and interpretable risk stratification is clinically important when advanced mechanical circulatory support is considered.
This was a retrospective, multi-database model development and validation study with exploratory application in a local VA-ECMO-treated AMI-CS cohort. An in-hospital mortality prediction model was developed in AMI-CS patients who did not receive ECMO treatment using the MIMIC-IV database. Candidate measurements were summarized using the worst values accumulated during the first 24 h after ICU admission. Variable shrinkage was performed using LASSO logistic regression with 10-fold cross-validation, and the model was established using multivariable logistic regression. Internal validation included the original fixed-structure bootstrap and an additional full-pipeline bootstrap sensitivity analysis. The latter repeated preprocessing, LASSO selection, post-LASSO handling, and model refitting within each resample. External validation was performed in the eICU cohort. The model was then applied exploratorily to the local VA-ECMO-treated AMI-CS cohort to describe model transportability and the relationship between observed and predicted outcomes.
The MIMIC-IV development cohort included 355 patients, of whom 127 died in hospital (35.77%). LASSO selected 8 clinical predictors. The apparent AUC was 0.829 (95% CI 0.785-0.874). After the final model was refitted in 200 fixed-structure bootstrap resamples, the optimism-corrected AUC was 0.814. In 500 full-pipeline bootstrap resamples, all repetitions were valid, the mean optimism was 0.0436, and the optimism-corrected AUC was 0.786 (empirical 2.5th to 97.5th percentile range: 0.745-0.832). The AUCs from the MIMIC-IV complete-case and multiple-imputation sensitivity analyses were 0.820 and 0.840, respectively. In the eICU complete-case cohort, the AUC was 0.806 (95% CI 0.691-0.921), O/E was 0.733, the calibration intercept was - 0.986, and the calibration slope was 0.671. After multiple imputation in all 224 eligible eICU patients, the AUC was 0.771, O/E was 0.754, the calibration intercept was - 0.756, and the calibration slope was 0.528. The local cohort included 40 VA-ECMO-treated patients. Overall observed mortality was 42.5% (95% CI 27.0-59.1), mean predicted mortality was 59.2% (95% CI 50.6-67.2), and O/E was 0.717 (95% CI 0.418-1.149).
This study developed and externally validated a mortality risk model for patients with acute myocardial infarction complicated by cardiogenic shock. The model may provide a research reference for early risk stratification and individualized assessment. Uncertainty in variable selection and cross-population calibration drift limit its direct clinical application. Prospective multicenter studies are required for further validation and to evaluate its role in VA-ECMO patient selection.

PMID:
42934677
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement